ATMPS LTD
Company number 12415491 · Monitor this company
Executive summary
ATMPS LTD exhibits significant financial weakness with negative net assets worsening to -£247k and persistent liquidity shortfalls. The company’s inability to cover current liabilities from current assets, coupled with increased long-term creditor exposure, undermines its capacity to service debt. Credit approval is not recommended without substantial improvement in financial position or operational turnaround.
Shareholders' funds
-£93,345
Balance sheet as at 2023-01-31
What it does
This company sells stuff to other companies
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-01-21
- Employees
- 0 (2025 accounts)
- Registered office
- 71-75 Shelton Street, London, Greater London, United Kingdom, WC2H 9JQ
- Postcode
- WC2H 9JQ
- Capital
- 106 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-01-31
- Next due by
- 2026-10-31
- Financial year end
- 31 January
Confirmation statement
- Last statement dated
- 2026-05-08
- Next due by
- 2027-05-22
Nature of business (SIC)
- 62020 Information technology consultancy activities
- 62090 Other information technology service activities
Officers 1 current · 1 resigned
Contact details
- Website
- atmps.org
ATMPS Ltd provides Hataali, a unique vein to vein, fully digital, secure technical solution for the Personalised Medicine sector using innovative blockchain technology. Hataali provides a platform for cell and gene therapy treatments, rare diseases and stem cell therapies.
Previous company names
| Name | Date changed |
|---|---|
| CELL GENE DATA TECH LTD | 2020-03-02 |
Among its peers
Among the oldest 25%
of 5,388 similar companies in WC, trading since 2020
Competitors London
This company ranks 3132 among information technology consultancy activities in London.
The class of 2020
30%
of the 15,007 companies in this sector incorporated in 2020 are still active today; 67% have since been dissolved.
A fact about the year, not a forecast for this company.